Oxybutynin Chloride

This page contains recent news articles, when available, and an overview of Oxybutynin Chloride but does not offer medical advice. You should contact your physician with regard to any health issues or concerns.


Overview:

Oxybutynin Chloride
(when available)

Pharmacology and use:
Oxybutynin is an antispasmodic, anticholinergic agent indicated for the treatment of overactive bladder with symptoms of urge urinary incontinence, urgency, and frequency. Oxybutynin relaxes bladder smooth muscle. Oxybutynin exhibits only one-fifth of the anticholinergic activity of atropine on the rabbit detrusor muscle, but four to ten times the antispasmodic activity. Antimuscarinic activity resides predominantly in the R-isomer. For the treatment of overactive bladder

Mechanism Of Action:
Oxybutynin exerts a direct antispasmodic effect on smooth muscle and inhibits the muscarinic action of acetylcholine on smooth muscle. No blocking effects occur at skeletal neuromuscular junctions or autonomic ganglia (antinicotinic effects).

News Articles on Oxybutynin

Oxybutynin chloride topical gel: a new formulation of an established ...  -  ‎Dec 31, 2009‎
Oxybutynin chloride topical gel (OTG) (Gelnique), Watson Pharmaceuticals, Corona, CA, USA) was approved in January 2009 by the US FDA. ... UroToday

Watson gets boost in Q3 from new product introductions  -  ‎Nov 4, 2009‎
Rapaflo (silodosin) and the overactive bladder treatment Gelnique (oxybutynin chloride) – contributed also, with revenues of more than $112 million. Drug Store News (blog)

Watson Pharmaceuticals: Income Statement Analysis for the September 2009 Quarter  -  ‎Nov 8, 2009‎
Watson reported that they incurred additional costs when launching the RAPAFLO ® (silodosin) and Gelnique (oxybutynin chloride) products. ... Seeking Alpha (blog)

… Final FDA Okay for Oxybutynin Chloride Extended-release Tablets  -  Nov 10, 2006
Oxybutynin Chloride ER Tablets are the generic version of Alza Corporation's Ditropan XL Extended-release Tablets. Ditropan XL had US sales of approximately ... StreetInsider.com - StreetInsider.com (subscription)

… Final FDA Approval for Oxybutynin Chloride Extended-release...  -  Nov 13, 2006
Mylan Receives Final FDA Approval for Oxybutynin Chloride Extended-release Tablets. from M2 Presswire. Highbeam Research – FREE Trial. Pay-Per-View - M2 Presswire - HighBeam Research

Generic Drugs; US FDA grants tentative approval for Oxybutynin...  -  Feb 14, 2005
Oxybutynin Chloride ER Tablets are the generic version of Alza Corporation's Ditropan XL Extended-release Tablets. Mylan believes it is the first generic ... Pay-Per-View - Pharma Business Week - Factiva, from Dow Jones

Article: FDA: Bladder drug needs stronger warning - The Record...  -  Apr 10, 2007
Drug Administration (FDA) to market Ditropan(R) XL (oxybutynin chloride), ... Roussel, Inc. to acquire rights to the Ditropan(R) (oxybutynin chloride) ... Pay-Per-View - The Record - HighBeam Research

Press Release: Watson Receives FDA Approval of Potassium Chloride …  -  Jun 3, 2008
Article: Mylan Receives Final FDA Approval for Oxybutynin Chloride . ... Abbreviated New Drug Applications (ANDAs) for Oxybutynin Chloride Extended-release ... Pay-Per-View - PR Newswire - HighBeam Research

Oxybutynin chloride extended-release tablets.(NEW GENERICS)(ALZA …  -  Jan 8, 2007
Three new approvals have been received for Oxybutynin chloride extended-release tablets as a generic alternative to Alza Corp. ... Free with registration - Drug Topics - AccessMyLibrary.com

… Final FDA Approval for Oxybutynin Chloride Extended-release...  -  Nov 10, 2006
Mylan Receives Final FDA Approval for Oxybutynin Chloride Extended-release Tablets. from PR Newswire. Highbeam Research – FREE Trial. Pay-Per-View - PR Newswire - HighBeam Research

Generic Drugs; US FDA grants tentative approval for Oxybutynin...  -  Feb 15, 2005
Oxybutynin Chloride ER Tablets are the generic version of Alza Corporation's Ditropan XL Extended-release Tablets. Mylan believes it is the first generic ... Pay-Per-View - Life Science Weekly - Factiva, from Dow Jones

Watson Announces Oxybutynin Topical Gel NDA Accepted for Filing By …  -  May 28, 2008
Inc. , a leading specialty pharmaceutical company, announced today that its New Drug Application (NDA) for oxybutynin chloride topical gel (OTG), ... RedOrbit

Generic Drugs; US FDA grants tentative approval for Oxybutynin...  -  Feb 20, 2005
Oxybutynin Chloride ER Tablets are the generic version of Alza Corporation's Ditropan XL Extended-release Tablets. Mylan believes it is the first generic ... Pay-Per-View - Medical Letter on the CDC & FDA - Factiva, from Dow Jones

Oxybutynin chloride extended-release tablets.  -  Jul 9, 2007
TEVA will also market oxybutynin chloride extended-release tablets in 5- and 10-mg strengths. This generic version of Alza Corp.'s Ditropan XL is indicated ... $9.94 - Drug Topics - Alacra Store

… Final FDA Approval for Oxybutynin Chloride Extended-release...  -  Nov 13, 2006
M2 PRESSWIRE-13 November 2006-News Flash: Mylan Receives Final FDA Approval for Oxybutynin Chloride Extended-release Tablets.(C)1994-2006 M2 COMMUNICATIONS ... $4.95 - M2 Presswire - ECNext

… Tentative Approval for Oxybutynin Chloride Extended-release...  -  Jan 18, 2005
Oxybutynin Chloride ER Tablets are the generic version of Alza Corporation's Ditropan XL(R) Extended-release Tablets. Mylan believes it is the first generic ... Pay-Per-View - PR Newswire - HighBeam Research

Oxybutynin chloride extended-release tablets.  -  Jan 8, 2007
Oxybutynin chloride extended-release tablets. Three new approvals have been received for Oxybutynin chloride extended-release tablets as a generic ... $9.94 - Drug Topics - Alacra Store

Oxybutynin chloride extended-release tablets.(NEW GENERICS)(ALZA …  -  Jan 8, 2007
Three new approvals have been received for Oxybutynin chloride extended-release tablets as a generic alternative to Alza Corp. $4.95 - Drug Topics - ECNext

Oxybutynin chloride extended-release tablets.(NEW GENERICS)(Brief …  -  Jul 9, 2007
TEVA will also market oxybutynin chloride extended-release tablets in 5- and 10-mg strengths. This generic version of Alza Corp.'s Ditropan XL is indicated ... $4.95 - Drug Topics - ECNext

FDA tentative generics approvals--2005.(Special Report)(Illustration)  -  Feb 27, 2006
GENERIC DRUG NAME APPLICANT JANUARY Finasteride tablets USP, 5 mg Ivax Pharmaceuticals Inc. Oxybutynin chloride extended- Mylan Pharmaceuticals release ... Free with registration - Chain Drug Review - AccessMyLibrary.com

Press Release: IMPAX Receives Final FDA Approval. - M2 Presswire | …  -  Nov 10, 2006
Article: Mylan Receives Final FDA Approval for Oxybutynin Chloride ... M2 Presswire; November 13, 2006 ; 700+ words ... ... Alza Corporation's Ditropan XL ... Pay-Per-View - M2 Presswire - HighBeam Research

… US District Court Decision on DITROPAN XL(R) (Oxybutynin Chloride)  -  Sep 28, 2005
ALZA Corporation to Appeal US District Court Decision on DITROPAN XL(R) (Oxybutynin Chloride) Patent. from PR Newswire. Highbeam Research – FREE Trial. Pay-Per-View - PR Newswire - HighBeam Research

Global top 300 multisource generic pharmaceuticals by sales, …  -  Apr 28, 2008
Watson Labs Hydrocodone-acetaminophen 00591085305 91 Sandoz Ondansetron HCI 00781525831 92 Mylan Oxybutynin chloride ER 00378661001 93 Ethex MetoProlol ... $20.00 - Chain Drug Review - Alacra Store

Press Release: Mylan Announces Supply Agreement with Ortho-McNeil …  -  Dec 20, 2005
PR Newswire; September 28, 2005 ; 700+ words ... ... decision that a patent on DITROPAN XL(R) (oxybutynin chloride ... held that the patent on DITROPAN XL ... Pay-Per-View - PR Newswire - HighBeam Research

FDA tentative generics approvals--2005.(Special Report)(Illustration)...  -  Feb 27, 2006
Oxybutynin chloride extended- Mylan Pharmaceuticals release tablets, 5 mg Inc. Estradiol and estradiol/norgestimate Barr Laboratories Inc. tablets, ... Pay-Per-View - Chain Drug Review - HighBeam Research

Top 300 multisource generics by manufacturer and NDC11 number.(RX/ …  -  Apr 28, 2008
Ondansetron HCI00781525831 92 Mylan Oxybutynin chloride ER 00378661001 93 ... chloride 58177000108 259Mylan Oxybutynin chloride ER 00378660501 260Dey ... Pay-Per-View - Chain Drug Review - HighBeam Research

Press Release: Watson Announces Oxybutynin Topical Gel NDA …  -  May 28, 2008
PR Newswire; October 8, 2008 ; 700+ words ... ... oxybutynin chloride topical gel (OTG), its investigational therapy for overactive bladder (OAB). ... Pay-Per-View - PR Newswire - HighBeam Research

Press Release: Fougera First-To-Market With Metronidazole Topical Gel...  -  Jun 6, 2006
About Oxybutynin Chloride Topical Gel (OTG) OTG is a clear, odorless, ... GELNIQUE(TM) (oxybutynin chloride) gel 10%, first and only topical gel for the ... Pay-Per-View - PR Newswire - HighBeam Research

… US District Court Decision on DITROPAN XL(R) (Oxybutynin Chloride)...  -  Sep 28, 2005
...today the intention to appeal a US District Court decision that a patent on DITROPAN XL(R) (oxybutynin chloride) extended release tablets is invalid. ... $4.95 - PR Newswire - ECNext

Article: The right message, better results: understanding--and...  -  Apr 1, 2007
Ditropan XL minimizes first-pass metabolism by ... day system. The important lesson for Ditropan XL (oxybutynin chloride) was that drug ... ... Pay-Per-View - Medical Marketing & Media - HighBeam Research

FDA first-time generics approvals--2006.(Special Report)(Statistical...  -  Feb 19, 2007
USA Inc. Metrogel vaginal gel 0.75% gel NOVEMBER Oxybutynin chloride Mylan PharmaceuticalsDitropan XL extended-release Inc. extended-release tablets, ... Pay-Per-View - Chain Drug Review - HighBeam Research

Mylan Announces Supply Agreement with Ortho-McNeil on Oxybutynin.  -  Dec 20, 2005
Corporation relating to oxybutynin chloride extended release tablets, a generic version of DITROPAN XL(R) oxybutynin chloride extended release tablets. ... Free with registration - PR Newswire - AccessMyLibrary.com

IMPAX Prevails in Alza's Appeal Related to Generic Version of...  -  Sep 7, 2006
..."We received tentative approval for Oxybutynin Chloride 5, 10 and 15 mg Extended Release Tablets in February 2005. Final approval is now dependent on the US ... Free with registration - Business Wire - AccessMyLibrary.com

Urinary Incontinence: Choices in Medical Therapy for Overactive...  -  Apr 1, 2007
Once daily controlled versus immediate release oxybutynin chloride for urge urinary incontinence. OROS Oxybutynin Study Group. J Urol. 1999;161:1809-1812. ... $4.95 - Consultant - ECNext

Newer agents for the management of overactive bladder.(Clinical...  -  Dec 15, 2006
Ditropan (oxybutynin chloride) [Prescribing information]. ... Long-term safety of extended-release oxybutynin chloride in a community-dwelling population of ... $4.95 - American Family Physician - ECNext

National Association for Female Executives (NAFE) Launches Healthcare...  -  Jan 25, 2005
DITROPAN XL(R) (oxybutynin chloride) is indicated to help control the symptoms of overactive bladder -- urinating eight or more times a day, sudden urges to ... $4.95 - PR Newswire - ECNext

Impax drug gets final FDA approval  -  Nov 10, 2006
This formulation of Ditropan XL (Oxybutynin Chloride) comes out of a partnership between Impax and Israel-based Teva Pharmaceutals. Teva (NASDAQ: TEVA) will ... Bizjournals.com

Article: STROKE Controlling homocyste ... - The Washington Post | …  -  Mar 8, 2005
Article: Watson's GELNIQUE(TM) (oxybutynin chloride) Gel 10% Approved by ... PR Newswire; January 27, 2009 ; 700+ words ... ... only topical gel for the ... Pay-Per-View - Washington Post - HighBeam Research

ChineseWorldNet.com ç’°ç?ƒè²¡ç¶“北美股票-媒體中心-Quote 123  -  Oct 8, 2008
...報價, 研究資料) 25.60 : 公�宣佈,調查員發表oxybutynin chloride局部塗抹藥�的 臨床藥�數據,oxybutynin chloride治療膀胱�動症。 ... 環�財經

United States top 250 generic pharmaceuticals by sales, and …  -  Feb 4, 2008
Morphine sulfate 147268926 83 Actavis Lovastatin 146876028 84 Dava Oxycodone HCl 146384539 85 Mylan Oxybutynin chloride ER 146381632 86 Dr. Reddy's Labs. ... $20.00 - Chain Drug Review - Alacra Store

Business news briefs: 11/11/06  -  Nov 11, 2006
Mylan Laboratories said it received final approval from the Food and Drug Administration to market oxybutynin chloride in tablet form. ... Pittsburgh Post-Gazette - Pittsburgh Post Gazette

Therapeutic/Pharmacologic Approaches to Urinary Incontinence in Older...  -  Sep 23, 2008
Zorzitto, ML, Holliday, PJ, Jewett, MA, Herschorn, S. & Fernie, GR Oxybutynin chloride for geriatric urinary dysfunction: a double-blind placebo-controlled ... Nature.com

Article: College may endow memory to old brains.(Neuroscience)(Brief ...  -  Mar 26, 2005
Article: New Data Suggest that GELNIQUE(R) (oxybutynin chloride) gel 10% ... PR Newswire; September 29, 2009 ; 700+ words ... ... announced findings of a ... Pay-Per-View - Science News - HighBeam Research

Generics makers keep new products coming.(RX/GENERICS)(Statistical …  -  Sep 17, 2007
Meloxicam $88799274.56 Barr Desmopressin Acetate $87593179.91 Teva USA Nifediac CC $86804287.67 Mylan Oxybutynin Chloride ER $85921736.22 Barr Aviane ... Free with registration - Chain Drug Review - AccessMyLibrary.com

Bladder spasm at 3 am, when should I give Ditropan  -  Dec 27, 2008
Per the drug manufacturer's guidelines, oxybutynin chloride (Ditropan, Ditropan XL) needs to be taken regularly -- 2 to 3 times a day when using Ditropan, ... HealthCentral.com

Friday's biggest stock gainers and decliners.  -  Nov 10, 2006
Mylan Laboratories Inc. said it has received final approval from the US Food and Drug Administration for its Oxybutynin Chloride extended-release tablets in ... Free with registration - America's Intelligence Wire - AccessMyLibrary.com

(JNJ) SqueezeTrigger Price is $62.442. There is $1,387,657,735.00...  -  Mar 4, 2008
DOXIL (doxorubicin HCI liposome injection), a cancer treatment; DITROPAN XL (oxybutynin chloride), for the treatment of overactive bladder; ... Free with registration - M2 Presswire - AccessMyLibrary.com

Suffering urinary incontinence in silence; Surveys show those who...  -  Nov 16, 2005
Urge incontinence is often treated with drugs like tolterodine, sold as Detrol, and oxybutynin chloride, sold as Ditropan, that relax muscles in the urinary ... Pay-Per-View - Contra Costa Times - Factiva, from Dow Jones

IMPAX Receives Final FDA Approval for Generic Ditropan(R) XL 5 mg …  -  May 9, 2007
...(Oxybutynin Chloride) 5 mg and 10 mg Extended-release Tablets. Alza Pharmaceuticals markets Ditropan XL for the treatment of urge urinary incontinence. ... Genetic Engineering News - Genetic Engineering News (press release)

Watson Announces Positive Data for Its New Investigational Products...  -  May 21, 2008
...or prostate enlargement) and a pharmacokinetic study of oxybutynin chloride topical gel (OTG), an investigational product for overactive bladder. ... RedOrbit

Results of Two Epidemiological Studies Provide Important New Clinical...  -  Feb 16, 2006
ORTHO TRI-CYCLEN(R) LO (norgestimate/ethinyl estradiol), DITROPAN XL(R) (oxybutynin chloride), and ELMIRON(R) (pentosan polysulfate sodium). Free with registration - PR Newswire - AccessMyLibrary.com

Healthcare Companies Making News!  -  May 9, 2007
...(Oxybutynin Chloride) 5 mg and 10 mg Extended-release Tablets. Alza Pharmaceuticals markets Ditropan XL for the treatment of urge urinary incontinence. ... Free with registration - M2 Presswire - AccessMyLibrary.com

United States top 200 generic drugs by sales in units for 2004  -  Feb 28, 2005
116 Lidocaine viscous 159390 117 Hydroxychloroquine 157243 118 Promethazine VC w/codeine 157011 119 Oxybutynin chloride 156529 120 Hydrocodone compound ... $20.00 - Chain Drug Review - Alacra Store

Inland Valley Daily Bulletin (Ontario, CA)  -  May 29, 2008
...or prostate enlargement) and a pharmacokinetic study of oxybutynin chloride topical gel, an investigational product for overactive bladder. ... $3.50 - Inland Valley Daily Bulletin - NewsBank

The tools you can't do without: pachymeters? Topographers? Retinal …  -  Aug 15, 2007
You got patients on oxybutynin chloride? Get the best darn wet vac money can buy! Wait--they're how much? OK, work your way down, but get one. ... Free with registration - Review of Optometry - AccessMyLibrary.com

Press Release: Watson Announces Positive Data for Its Investigational...  -  Oct 8, 2008
...announced today that investigators presented clinical pharmacokinetic data on oxybutynin chloride topical gel (OTG), its investigational therapy for ... Pay-Per-View - PR Newswire - HighBeam Research

Premature ejaculation drug helps control, satisfaction and time  -  May 25, 2005
...patients the most advanced options in urology with products such as ELMIRON® (pentosan polysulfate sodium) and DITROPAN XL® (oxybutynin chloride). ... Medical News Today - Medical News Today (press release)

United States top 200 generic pharmaceuticals by retail sales in...  -  Feb 19, 2007
Naproxen Sodium 37208 -2.5 191 Butorphanol NS 36908 -10.5 192 Oxybutynin Chloride 36670 43.2 193 Ciclopirox 36570 0.9 194 PhosLo 36328 33.4 195 Atenolol ... $20.00 - Drug Topics - Alacra Store

Practice Guidelines  -  Jul 1, 2005
...for treatment or prevention of any type of urinary incontinence. The anticholinergic drugs oxybutynin chloride (Ditropan) and tolterodine (Detrol) AAFP News Now

New Survey Sheds Light on Mistaken Identities of Interstitial...  -  Aug 17, 2006
ORTHO TRI-CYCLEN(R) LO (norgestimate/ethinyl estradiol), DITROPAN XL(R) (oxybutynin chloride), and ELMIRON(R) (pentosan polysulfate sodium). ... Free with registration - PR Newswire - AccessMyLibrary.com

Top 200 generic drugs by units in 2006.(COMMUNITY PRACTICE)( …  -  Mar 5, 2007
Rx 2492 -1.3 143 Carbidopa/Levodopa 2479 10.8 144 Nystatin Topical 2475 5.2 145 Fluocinonide 2469 1.2 146 Oxybutynin Chloride 2463 11.1 147 Tetracycline ... $4.95 - Drug Topics - ECNext

IMPAX Receives Tentative FDA Approval for Generic Version of Ditropan...  -  Feb 2, 2005
...(Oxybutynin Chloride) 5, 10 and 15 mg Extended Release Tablets. Alza Pharmaceuticals markets Ditropan XL for the treatment of urge urinary incontinence. ... Free with registration - Business Wire - AccessMyLibrary.com

IMPAX's ANDA for generic of Ditropan XL gets tentative FDA nod  -  Feb 3, 2005
...(Oxybutynin Chloride) 5, 10 and 15 mg Extended Release Tablets. Alza Pharmaceuticals markets Ditropan XL for the treatment of urge urinary incontinence. ... pharmabiz.com

Tolterodine Extended-Release Does Not Impair Memory In Patients With ...  -  Dec 1, 2006
The results also showed, however, that oxybutynin chloride ER (Ditropan-XL®), 20 mg per day, reduced memory to the same degree as might be expected with 20 ... Medical News Today - Medical News Today (press release)

New Survey Reveals Birth Control Not Part of 'Pill Lo' Talk -- Life...  -  Jul 26, 2006
ORTHO TRI-CYCLEN(R) LO (norgestimate/ethinyl estradiol), DITROPAN XL(R) (oxybutynin chloride), and ELMIRON(R) (pentosan polysulfate sodium). ... Free with registration - PR Newswire - AccessMyLibrary.com

Briefs: Dick's Sporting Goods eyes new stores in West  -  Nov 11, 2006
Also given final approval was Mylan's Oxybutynin Chloride tablets, the generic form of Alza Corp.'s Ditropan XL, an antispasmodic drug used to treat ... pittsburghlive.com

Product News from the 11/14/06 News Brief  -  Nov 14, 2006
The FDA has granted Mylan Laboratories approval for its generic version of Alza Corporation's Ditropan XL (oxybutynin chloride extended-release) tablets. ... Medical Marketing & Media - Medical Marketing and Media

Survey Sheds Light On Mistaken Identities Of Interstitial Cystitis -...  -  Aug 20, 2006
ORTHO TRI-CYCLENÆ LO (norgestimate/ethinyl estradiol), DITROPAN XLÆ (oxybutynin chloride) and ELMIRONÆ (pentosan polysulfate sodium). ... Medical News Today - Medical News Today (press release)

Report Shows Popular Birth Control Pill, Ortho Tri-Cyclen(R) LO, Not ...  -  May 11, 2006
ORTHO TRI-CYCLEN(R) LO (norgestimate/ethinyl estradiol), DITROPAN XL(R) (oxybutynin chloride), and ELMIRON(R) (pentosan polysulfate sodium). ... Medical News Today - Medical News Today (press release)

ALSO NOTED: Roche unveils Fuzeon data; Palatin pulls agent; Acambis …  -  Dec 19, 2005
Mylan Pharmaceuticals has entered into two agreements with Ortho-McNeil Pharmaceutical and Alza Corporation relating to oxybutynin chloride extended release ... FierceBiotech

Inappropriate meds linked to adverse nursing home events.( )  -  Feb 7, 2005
The most common inappropriate drugs include propoxyphene, diphenhydramine, hydroxyzine, oxybutynin chloride, amitriptyline hydrochloride, ... Free with registration - Drug Topics - AccessMyLibrary.com

Global top 200 generic drugs by retail sales in dollars and percent …  -  Feb 21, 2005
157 Benazepril/HCTZ 28705 NA 158 Digoxin 28631 35.5 159 Methadone HCl Non-In 26724 5.0 160 Cimetidine 26266 -34.0 161 Oxybutynin Chloride 26074 -8.5 162 ... $20.00 - Drug Topics - Alacra Store

Top 200 generic drugs by retail dollars in 2006.(COMMUNITY PRACTICE …  -  Feb 19, 2007
Naproxen Sodium 37208 -2.5 191 Butorphanol NS 36908 -10.5 192 Oxybutynin Chloride 36670 43.2 193 Ciclopirox 36570 0.9 194 PhosLo 36328 33.4 195 Atenolol ... $4.95 - Drug Topics - ECNext

Article: Carotenoid lycopene alleviates age-related prostate enlargeme...  -  Feb 1, 2008
...benign prostatic hyperplasia (BPH, or prostate enlargement) and a pharmacokinetic study of oxybutynin chloride topical gel (OTG), an investigational ... ... Pay-Per-View - Food Engineering & Ingredients - HighBeam Research

The management of urinary incontinence.(CONTINUING EDUCATION: …  -  Sep 17, 2007
The extended-release system is an osmotically active bilayer core designed to deliver a controlled amount of oxybutynin chloride over a 24-hour period into ... $4.95 - Drug Topics - ECNext

United States top 190 multisource generic drugs ranked by sales in …  -  Sep 29, 2008
Metoprolol succinate 112 Mylan Oxybutynin chloride ER 113 Mylan Fentanyl 114 Dr. Reddy's Labs Zolpidem tartrate 115 Par Pharm. Ranitidine HCl 116 Danbury ... $20.00 - Chain Drug Review - Alacra Store

Urinary Incontinence; US FDA grants tentative approval for generic …  -  Mar 4, 2005
...company's Abbreviated New Drug Application (ANDA) for a generic version of Ditropan XL (Oxybutynin Chloride) 5, 10, and 15 mg Extended Release Tablets. ... Pay-Per-View - Drug Week - Factiva, from Dow Jones

Tenetative US appro for Mylan's oxybutynin.(Brief Article)  -  Jan 24, 2005
...its Abbreviated New Drug Applications for oxybutynin chloride extended-release tablets, 5mg and 10mg, the generic version of Alza Corp's Ditropan XL. ... $4.95 - Pharma Marketletter - ECNext

Urinary Incontinence; US FDA grants tentative approval for generic …  -  Feb 28, 2005
...company's Abbreviated New Drug Application (ANDA) for a generic version of Ditropan XL (Oxybutynin Chloride) 5, 10, and 15 mg Extended Release Tablets. ... Pay-Per-View - Health & Medicine Week - Factiva, from Dow Jones

Watson presents data on Ph III urology products.  -  Jun 2, 2008
Oxybutynin chloride topical gel, an investigational product for overactive bladder, produced similar serum levels to Oxytrol, an already-approved oxybutin ... $9.94 - Pharma Marketletter - Alacra Store

Simple questions can help uncover urinary incontinence.(Women's …  -  Feb 15, 2007
Ditropan XL (oxybutynin chloride), once-a-day treatment for overactive bladder in adults, is now available in a 15-mg tablet as well as 5- and 10-mg sizes. ... Pay-Per-View - Family Practice News - HighBeam Research

Press Release: Watson Announces Positive Data for Its New …  -  May 21, 2008
...or prostate enlargement) and a pharmacokinetic study of oxybutynin chloride topical gel (OTG), an investigational product for overactive bladder. ... Pay-Per-View - PR Newswire - HighBeam Research

Mylan Laboratories.(Pipeline) | Article from Medical Marketing &...  -  Dec 1, 2006
Mylan Laboratories won approval for its generic version of Alza Corporation's Ditropan XL (oxybutynin chloride extended-release) tablets. ... Pay-Per-View - Medical Marketing & Media - HighBeam Research

(JNJ) SqueezeTrigger Price is $63.457. There is $948,271,368.75 That ...  -  Jul 16, 2007
DOXIL (doxorubicin HCI liposome injection), a cancer treatment; DITROPAN XL (oxybutynin chloride), for the treatment of overactive bladder; ... $4.95 - M2 Presswire - ECNext

Acusphere.(MANUFACTURERS) | Article from Medical Marketing & …  -  Jul 1, 2007
Mylan Laboratories won approval for its generic version of Alza Corporation's Ditropan XL (oxybutynin chloride extended-release) tablets. ... Pay-Per-View - Medical Marketing & Media - HighBeam Research

IMPAX'S GENERIC DITROPAN XL APPROVED BY FDA  -  Nov 14, 2006
...approval to its abbreviated new drug application (ANDA) for a generic version of Ditropan XL (oxybutynin chloride) Extended-Release Tablets, 15 mg. ... Pay-Per-View - FDAnews Drug Pipeline Alert - Factiva, from Dow Jones

Nursing grand rounds: multiple sclerosis.  -  Feb 1, 2005
She also takes oxybutynin chloride extended-release tablets, (Ditropan XL), which relax the bladder (ie, detrusor muscle) and relieve urgency and ... $4.95 - Journal of Neuroscience Nursing - ECNext

Mylan Pharmaceuticals Inc.  -  Sep 17, 2007
During the past fiscal year Mylan was first to market with two major opportunities that the company was first to file: oxybutynin chloride ER tablets ... $9.94 - Chain Drug Review - Alacra Store

Press Release: FDA Warns Consumers About Potential Problems at Two …  -  Aug 11, 2008
Ditropan XL, Extended-release Tablets, 15 mg (Oxybutynin Chloride Extended-release Tablets 15 mg). The FDA also awarded the Company first-to-file ... ... Pay-Per-View - M2 Presswire - HighBeam Research

Mylan Laboratories.(Update) | Article from Medical Marketing & Media...  -  Jan 1, 2005
Mylan Laboratories won approval for its generic version of Alza Corporation's Ditropan XL (oxybutynin chloride extended-release) tablets. ... Pay-Per-View - Medical Marketing & Media - HighBeam Research

Hot Stocks to Watch! November 13, 2006.  -  Nov 13, 2006
New Drug Application (ANDA) for a generic version of Ditropan XL, Extended-release Tablets, 15 mg (Oxybutynin Chloride Extended-release Tablets 15 mg). ... $4.95 - M2 Presswire - ECNext

Suppliers keep pipeline flowing; medications for diverse conditions...  -  Jun 25, 2007
Teva has also announced the availability of oxybutynin chloride extended-release tablets. Copyright 2007 Racher Press Inc. $9.94 - Chain Drug Review - Alacra Store

Report Shows Popular Birth Control Pill, ORTHO TRI-CYCLEN(R) LO, Not …  -  May 9, 2006
ORTHO TRI-CYCLEN(R) LO (norgestimate/ethinyl estradiol), DITROPAN XL(R) (oxybutynin chloride), and ELMIRON(R) (pentosan polysulfate sodium). ... $4.95 - PR Newswire - ECNext

Press Release: Stiefel Laboratories, Inc. Announces Duac Topical Gel ...  -  Sep 25, 2006
New Research shows that oxybutynin topical gel may be a convenient alternative to currently ... pharmacokinetic data on oxybutynin chloride topical gel ... Pay-Per-View - PR Newswire - HighBeam Research

Article: Mylan gets approval.(RX RETAIL PHARMACY: Generic Drugs)( …  -  Jan 22, 2007
Mylan Laboratories won approval for its generic version of Alza Corporation's Ditropan XL (oxybutynin chloride extended-release) tablets. ... Pay-Per-View - Chain Drug Review - HighBeam Research

Tentative FDA OK for IMPAX generic Ditropan.(Food and drug …  -  Feb 7, 2005
...the company's Abbreviated New Drug Application for a generic version of Ditropan XL (oxybutynin chloride) 5mg, 10mg and 15mg extended-release tablets. ... $4.95 - Pharma Marketletter - ECNext

Press Release: New Report Provides an In-Depth Discussion on Recent …  -  Sep 14, 2007
Medical Marketing & Media; March 1, 2001 ; 700+ words ... ... oxybutynin chloride) was that drug delivery significantly changed the pharmacology ... Pay-Per-View - M2 Presswire - HighBeam Research

Article: A professional file card for Novartis' Exelon makes …  -  Oct 1, 2007
FDA cited the firm's promotional pieces for unsubstantiated superiority claims for Ditropan XL (oxybutynin chloride) as compared ... across-label" ... Pay-Per-View - Medical Marketing & Media - HighBeam Research

Press Release: CLEAR SKIN IS THIS SEASON'S "MUST-HAVE" …  -  Aug 24, 2006
New Research shows that oxybutynin topical gel may be a convenient alternative to currently ... pharmacokinetic data on oxybutynin chloride topical gel ... Pay-Per-View - PR Newswire - HighBeam Research

Article: Top 190 multisource generics by manufacturer and NDC11 …  -  Sep 29, 2008
Metoprolol succinate 112Mylan Oxybutynin chloride ER 113Mylan Fentanyl 114Dr. Reddy's LabsZolpidem tartrate 115Par Pharm. ... Pay-Per-View - Chain Drug Review - HighBeam Research

New generics.  -  Feb 21, 2005
Tentative approval has been granted to Mylan Laboratories, Pittsburgh, (724) 514-1800, for oxybutynin chloride extended-release tablets in 5-mg and 10-mg ... $9.94 - Drug Topics - Alacra Store

Press Release: National Association for Female Executives (NAFE) …  -  Jan 25, 2005
Business Wire; September 9, 2003 ; 700+ words ... ... generic version of Ditropan XL (Oxybutynin Chloride) Tablets, 15 mg. Ditropan XL Tablets are used for ... Pay-Per-View - PR Newswire - HighBeam Research

Article: Vitamin D deficit key in age-related morbidities: conditions...  -  Feb 15, 2007
Ditropan XL (oxybutynin chloride), once-a-day treatment for overactive bladder in adults, is now available in a 15-mg tablet as well as 5- and 10-mg sizes. ... Pay-Per-View - Family Practice News - HighBeam Research

Brand Names/Synonyms:
Oxybutynin Chloride is also known by the following brand names and/or synonymsCCRIS 1923; CHEMBANK1678; Ditropan; Ditropan Xl; Ditropan Xl;; HSDB 3270; Oxibutinina [Inn-Spanish]; Oxibutyninum; Oxybutinin; Oxybutynin; Oxybutynin Base; Oxybutynin Chloride; Oxybutynin Hydrochloride; Oxybutynine [Inn-French]; Oxybutyninum [Inn-Latin]; Oxytrol

Drug Category:
Oxybutynin Chloride is categorized under the following by the FDA: Anticholinergic Agents; Antispasmodics; Genitourinary Smooth Muscle Relaxants; ATC:G04BD04

Dosage Forms:
PATCH; SYRUP; TABLET; TABLET (EXTENDED-RELEASE)

Absorption:
Rapidly absorbed from gastrointestinal tract.

Interactions:
[an error occurred while processing this directive]



Chemical IUPAC Name:
4-diethylaminobut-2-ynyl2-cyclohexyl-2-hydroxy-2-phenyl-ethanoate





Health Home | Conditions | Cancer | Medications | Surgery | Vaccines


The Cancer News Network


Disclaimer:

Contact a physician with regard to health concerns. Email requests for further health information will be discarded.

The materials contained on this Web site are for informational purposes only and do not constitute health or medical advice. Use of information on this site does not create or constitute any kind of agreement or contract between you and the owners or users of this site, the owners of the servers upon which it is housed, or anyone else who is in any way connected with this site.

Many links on cancernewsnetwork.org lead to other sites. cancernewsnetwork.org does not sponsor, endorse or otherwise approve of the materials appearing in such sites. Nor is CancerNewsNetwork.org responsible for dead or misdirected links.

IF YOU NEED A LINK OR TEXT REMOVED FROM THIS PAGE PLEASE CONTACT cancernewsnetwork (at) live.com.
We will do our best to accommodate your request.



COPYRIGHT 2009 CANCERNEWSNETWORK | Privacy